Patent details

EP2950795 Title: METHOD FOR TREATING AND CURING LEISHMANIOSIS USING FEXININDAZOLE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2950795
WO Application Number:
US2014014134
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14705908.3
WO Publication Number:
WO2014121064
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
31/01/2014
Grant date:
25/04/2018
EP Publication Date:
09/12/2015
WO Publication Date:
07/08/2014
Claims Translations Received Date:
Claims Translation B1 Received Date:
03/07/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
25/04/2018
EP B1 Publication Date:
25/04/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
30/01/2034
Lapsed By Expiration Date:
Patent Validated Date:
25/07/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
11/10/2019
 
 

 

Name:
Boehringer Ingelheim Animal Health USA Inc.
Address:
3239 Satellite Boulevard, Bldg. 500, GA 30096, Duluth, United States of America (US)

Historical Applicant/holder

From:
11/10/2019
To:
11/10/2019

 

Name:
Boehringer Ingelheim Animal Health USA Inc.
Address:
3239 Satellite Boulevard, Bldg. 500, GA 30096, Duluth, United States of America (US)

From:
25/04/2018
To:
11/10/2019

 

Name:
Merial, Inc.
Address:
3239 Satellite Boulevard, Duluth GA 30096-4640, United States of America (US)

Agent

Name:
ir. H.A. Witmans c.s.
From:
24/07/2018
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
POLLMEIER, Matthias
Address:
40593 Düsseldorf, France (FR)

2

Name:
BLAIR, Jeffrey, Jynn
Address:
33100 Bordeaux, France (FR)

Priority

Priority Patent Number:
201361758918 P
Priority Date:
31/01/2013
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/4164; A61P 33/02;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
43/19
Publication date:
23/10/2019
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
43/19
Publication date:
23/10/2019
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
31/18
Publication date:
25/07/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
18/18
Publication date:
25/04/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201817
Publication date:
25/04/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC201902034A
Date Registered:
11/10/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Boehringer Ingelheim Animal Health USA Inc.
Address:
3239 Satellite Boulevard, Bldg. 500, GA 30096, Duluth, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC201902052A
Date Registered:
11/10/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Boehringer Ingelheim Animal Health USA Inc.
Address:
3239 Satellite Boulevard, Bldg. 500, GA 30096, Duluth, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/01/2026
Annual Fee Number:
13
Annual Fee Amount:
700 Euro
Last Annual Payment Date:
21/01/2025
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
600 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
24/07/2018 Outgoing Correspondence Letter no formal defects 1 PDF /8/2/2/4/6/0800264228/docs/ep14705908.3_2_219131l271.pdf
03/07/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /8/2/2/4/6/0800264228/docs/ep14705908.3_0_incomingcorrespondenceelectronic20180703161017627.pdf
03/07/2018 Claims First filed claims 2 PDF /8/2/2/4/6/0800264228/docs/ep14705908.3_1_claims20180703161015932.pdf
03/07/2018 Incoming Correspondence Electronic Accompanying letter incoming document 1 PDF /8/2/2/4/6/0800264228/docs/ep14705908.3_3_incomingcorrespondenceelectronic20180703161016777.pdf